Paying for Neulasta® (pegfilgrastim) Onpro® | Neulasta® Onpro®

Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the... Read More

You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to return to the consumer site, please click CANCEL.

The majority of commercial and Medicare plans cover Neulasta® and Neulasta® Onpro®

Most prescriptions cost $5 or less out of pocket per dose of Neulasta®

For more information on paying for Neulasta® Onpro®, find your insurance type below.

Amgen is committed to help ensure you will be able to get Neulasta® Onpro® at an affordable cost.

The list price for Neulasta® is $6231* per dose. Neulasta® is a single dose administered once per chemotherapy cycle. Most patients do not pay the list price. Your actual cost will vary. Talk to your insurance provider.

*List price is also referred to as wholesale acquisition cost or WAC. WAC is the price at which Amgen sells its products to wholesalers.

The guide below will help you get a better idea of what you may expect to pay

I have commercial insurance

(eg, self-purchased or through an employer)

I am on Medicare

I am on Medicaid

I am uninsured

aa360 logo


That's why we created Amgen Assist 360™. Assistance designed to support you throughout your treatment journey so you can focus on what's most important to you.

Monday through Friday — 9:00 am to 8:00 pm ET
resources icon

How we can help


Amgen nurse ambassadors provide a single point of contact who can help you find the resources that are most important to you.* Let our nurses provide personal support related to your financial and emotional wellness. Whatever you need, we’re here to help!


Whatever insurance you have—even if you have none—Amgen Assist 360™ can help you understand how your Amgen medicine may be covered, and refer you to programs that may be able to help you afford it.*

  • If you have commercial insurance and are eligible, the Amgen FIRST STEP™ co-pay program can help. Please see details below
  • If you have government insurance like Medicare, we can refer you to independent nonprofit patient assistance programs that may be able to help you afford the co-pay cost of your medicine*,§
  • If you are uninsured, the Amgen Safety Net Foundation, a nonprofit patient assistance program sponsored by Amgen, may be able to help you access Amgen medicines at no cost

We can refer you to independent nonprofit organizations that may provide you with community resources, one-on-one counseling services, and local support groups.


Have questions about your Amgen medication? We can help you get the answers you need.

*Provided through independent nonprofit patient assistance programs; program eligibility is based on the nonprofit’s criteria. Amgen has no control over these programs and provides referrals as a courtesy only.

Patients should always talk to their healthcare provider about any medical decisions or concerns they have.

Terms, conditions, and program maximums apply. This program is not open to patients receiving prescription reimbursement under any federal, state, or government-funded healthcare program. Not valid where prohibited by law.

§Amgen Assist 360™ can refer patients to independent nonprofit patient assistance programs that may be able to help them afford the co-pay costs for their prescribed medicine.

3 ways to enroll

Download enrollment form
Submit your enrollment form for the Amgen Nurse Ambassador today!
phone icon

Call 1-888-4ASSIST

Monday through Friday
9:00 am to 8:00 pm ET

fax icon

Fax 1-888-407-9787

Mail Icon

Mail PO Box 220354
Charlotte, NC 28222-9924

Important Safety Information

Do not take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.

Before you receive Neulasta®, tell your healthcare provider about all of your healthcare conditions, including if you:
  • Have a sickle cell disorder
  • Have had severe skin reactions to acrylic adhesives
  • Are allergic to latex – The needle cap on the prefilled syringe contains dry natural rubber (derived from latex).
  • Have kidney problems
  • Are pregnant or plan to become pregnant. It is not known if Neulasta® may harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if Neulasta® passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible serious side effects of Neulasta®?
  • Spleen Rupture. Your spleen may become enlarged and can rupture while taking Neulasta®. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder tip area.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious Allergic Reactions. Neulasta® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate and sweating.
If you have an allergic reaction during the delivery of Neulasta®, remove the on-body injector for Neulasta® by grabbing the edge of the adhesive pad and peeling off the on-body injector. Get emergency medical help right away.
  • Sickle Cell Crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive Neulasta®.
  • Kidney injury (glomerulonephritis). Neulasta® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face or ankles, blood in your urine or dark colored urine, or you urinate less than usual.
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with Neulasta®.
  • Capillary Leak Syndrome. Neulasta® can cause fluid to leak from blood vessels into your body’s tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:
    • Swelling or puffiness and are urinating less than usual
    • Trouble breathing
    • Swelling of your stomach area (abdomen) and feeling of fullness
    • Dizziness or feeling faint
    • A general feeling of tiredness
  • Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received Neulasta®. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effect of Neulasta® is pain in your bones and in your arms and legs.

These are not all the possible side effects of Neulasta®. Call your healthcare provider for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.

Please see Neulasta® Patient Information.

Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only.

Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe co-packaged with the on-body injector (OBI) for Neulasta® (Neulasta® Onpro® kit).